| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | M Petri | |
| G K W Lam | |||
| P433 | issue | 5 Suppl 39 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | S120-32 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical and Experimental Rheumatology | Q15759225 |
| P1476 | title | Assessment of systemic lupus erythematosus | |
| P478 | volume | 23 |
| Q37144759 | A pilot investigation of the prevalence of US-detectable forefoot joint pathology and reported foot-related disability in participants with systemic lupus erythematosus |
| Q87649260 | Alexithymia, mood states and pain experience in systemic lupus erythematosus and rheumatoid arthritis |
| Q36087500 | Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies |
| Q60311597 | Anifrolumab effects on rash and arthritis: impact of the type I interferon gene signature in the phase IIb MUSE study in patients with systemic lupus erythematosus |
| Q37270868 | Antiphospholipid antibody profiles in lupus nephritis with glomerular microthrombosis: a prospective study of 124 cases |
| Q35958642 | Belimumab (benlysta): a breakthrough therapy for systemic lupus erythematosus |
| Q26748941 | Breakdown of Immune Tolerance in Systemic Lupus Erythematosus by Dendritic Cells |
| Q36842422 | Cambridge Neuropsychological Test Automated Battery in assessment of cognitive parameters in patients with systemic lupus erythematosus in relation to autoantibody profile |
| Q38237868 | Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus |
| Q92594228 | Changes of NADH Fluorescence from the Skin of Patients with Systemic Lupus Erythematosus |
| Q60311600 | Clinical response beyond the Systemic Lupus Erythematosus Responder Index: post-hoc analysis of the BLISS-SC study |
| Q92546042 | Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity |
| Q44945550 | Critique and appraisal of a study on sex disparities in systemic lupus erythematosus |
| Q38697343 | Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases. |
| Q34561606 | Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument |
| Q46223099 | Detection of asymptomatic cranial neuropathies in patients with systemic lupus erythematosus and their relation to antiribosomal P antibody levels and disease activity |
| Q37640271 | Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort |
| Q90324844 | Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study |
| Q35993027 | Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial |
| Q91584436 | Fasting triglycerides and glucose index: a useful screening test for assessing insulin resistance in patients diagnosed with rheumatoid arthritis and systemic lupus erythematosus |
| Q35559428 | Fetal microchimerism in kidney biopsies of lupus nephritis patients may be associated with a beneficial effect |
| Q48022368 | High frequency of Smith autoantibodies in Omani patients with systemic lupus erythematosus |
| Q30671571 | Integration of PKPD relationships into benefit-risk analysis |
| Q64884391 | Macrophage Activation Syndrome (MAS) in a Recently Released Prisoner with Systemic Lupus Erythematosus (SLE). |
| Q36513087 | Mercury in Hair Is Inversely Related to Disease Associated Damage in Systemic Lupus Erythematosus |
| Q38215698 | Neurology of rheumatologic disorders |
| Q34492782 | New classification criteria for systemic lupus erythematosus correlate with disease activity |
| Q50910971 | Pathways of impending disease flare in African-American systemic lupus erythematosus patients. |
| Q55387947 | Pediatric Systemic Lupus Erythematosus: Learning From Longer Follow Up to Adulthood. |
| Q34025881 | Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare |
| Q37322751 | Serum Cytokines Th1, Th2, and Th17 Expression Profiling in Active Lupus Nephritis-IV: From a Southern Chinese Han Population |
| Q26774880 | Statistical considerations for stopping systemic lupus erythematosus clinical trials earlier |
| Q37807147 | Systemic Lupus Erythematosus: Safe and Effective Management in Primary Care |
| Q55379196 | TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus. |
| Q42953771 | Targeting Notch signaling in autoimmune and lymphoproliferative disease |
| Q64272100 | Th17/Treg Ratio and Disease Activity in Systemic Lupus Erythematosus |
| Q39646545 | The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity. |
| Q37638666 | Urinary Albumin Levels are Independently Associated with Renal Lesion Severity in Patients with Lupus Nephritis and Little or No Proteinuria |
| Q92424604 | Urinary podocyte microparticles are associated with disease activity and renal injury in systemic lupus erythematosus |
| Q53311622 | Urine peptidomic biomarkers for diagnosis of patients with systematic lupus erythematosus. |
Search more.